Skip to main content
. 2020 Dec 5;33:106621. doi: 10.1016/j.dib.2020.106621

Table 2.

Distribution of responses in relation to COVID-19 knowledge-related variables.

Knowledge related questions Frequency Percentages
Spreading Can be spread from infected individuals cough or exhalation Yes 9905 98.4
No 162 1.6
Can be spread from infected individuals by touch Yes 8732 86.7
No 1335 13.3
Can be spread from wild animals Yes 2857 28.4
No 7210 71.6
Can be spread form infected individuals faces Yes 2350 23.3
No 7717 76.7
Can be spread from companion animals or pets such as cats and dogs Yes 3141 31.2
No 6926 68.8
Can be spread through parcels from infected countries Yes 2009 20.0
No 8058 80.0
Symptoms Has an incubation period ranging from 2 to 14 days Yes 9416 93.5
No 651 6.5
Individuals may not develop any symptoms Yes 6525 64.8
No 3542 35.2
The most common symptoms are fever, tiredness, and dry cough Yes 8500 84.4
No 1567 15.6
Individuals may develop respiratory problems Yes 8478 84.2
No 1589 15.8
Some individuals may have aches and pains, nasal congestion, runny nose, sore throat, or diarrhea. Yes 7525 74.7
No 2542 25.3
Individuals with comorbidities are more likely to develop serious illness (e.g., organ failure) Yes 6332 62.9
No 3735 37.1
Preventive measures Washing hands regularly for 20 s Yes 9801 97.4
No 266 2.6
Avoid touching eyes, nose, and mouth Yes 9602 95.4
No 465 4.6
Wearing masks is mandatory Yes 8897 88.4
No 1170 11.6
Avoiding close contact from the infected individuals Yes 9455 93.9
No 612 6.1
Maintain at least one-meter (three feet) distance between yourself and anyone who is coughing or sneezing. Yes 9076 90.2
No 991 9.8
Quarantine at home if you feel unwell and isolate the infected individual Yes 9244 91.8
No 823 8.2
Treatments Taking pills such as paracetamol Yes 3831 38.1
No 6236 61.9
To date, there is no vaccine and no specific antiviral medicine to prevent or treat COVID-2019 Yes 8919 88.6
No 1148 11.4